Marshall Wace North America’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $23.1M | Buy |
388,397
+135,649
| +54% | +$8.08M | 0.1% | 221 |
|
|
2021
Q2 | $17.2M | Sell |
252,748
-74,310
| -23% | -$5.07M | 0.07% | 282 |
|
|
2021
Q1 | $22.7M | Sell |
327,058
-110,818
| -25% | -$7.69M | 0.09% | 233 |
|
|
2020
Q4 | $33.6M | Sell |
437,876
-559,520
| -56% | -$43M | 0.15% | 165 |
|
|
2020
Q3 | $74.6M | Sell |
997,396
-359,222
| -26% | -$26.9M | 0.48% | 45 |
|
|
2020
Q2 | $85.4M | Buy |
1,356,618
+863,891
| +175% | +$54.4M | 0.56% | 39 |
|
|
2020
Q1 | $20.7M | Buy |
492,727
+131,969
| +37% | +$5.54M | 0.16% | 152 |
|
|
2019
Q4 | $16.4M | Buy |
360,758
+105,318
| +41% | +$4.78M | 0.08% | 224 |
|
|
2019
Q3 | $11.7M | Sell |
255,440
-15,649
| -6% | -$716K | 0.07% | 237 |
|
|
2019
Q2 | $15.9M | Sell |
271,089
-318,601
| -54% | -$18.7M | 0.1% | 177 |
|
|
2019
Q1 | $26.4M | Buy |
589,690
+168,164
| +40% | +$7.54M | 0.19% | 118 |
|
|
2018
Q4 | $16.4M | Buy |
421,526
+31,027
| +8% | +$1.21M | 0.16% | 120 |
|
|
2018
Q3 | $18M | Sell |
390,499
-333,789
| -46% | -$15.4M | 0.12% | 147 |
|
|
2018
Q2 | $31.6M | Buy |
724,288
+379,881
| +110% | +$16.6M | 0.18% | 131 |
|
|
2018
Q1 | $13.6M | Buy |
+344,407
| New | +$13.6M | 0.07% | 328 |
|
|
2017
Q3 | – | Sell |
-95,888
| Closed | -$1.63M | – | 1593 |
|
|
2017
Q2 | $1.63M | Buy |
+95,888
| New | +$1.63M | 0.01% | 799 |
|
|
2013
Q4 | $92K | Buy |
+1,568
| New | +$92K | ﹤0.01% | 671 |
|